KIORA PHARMACEUTICALS, INC. Gain (Loss) on Disposition of Assets
KIORA PHARMACEUTICALS, INC. (KPRX) reported Gain (Loss) on Disposition of Assets of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-03-25
- KIORA PHARMACEUTICALS, INC. gain (loss) on disposition of assets for the quarter ending 2022-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. gain (loss) on disposition of assets for the quarter ending 2022-03-31 was $4.21K.
- KIORA PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2025 was $0.00.
- KIORA PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2024 was -$3.76K.
- KIORA PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2023 was -$28.38K, a 773.93% decline from fiscal 2022.
- KIORA PHARMACEUTICALS, INC. gain (loss) on disposition of assets for fiscal 2022 was $4.21K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-25 | ||
| 2024-12-31 | -$3.76K 10-K · filed 2026-03-25 | ||
| 2023-12-31 | -$28.38K 10-K · filed 2025-03-25 | ||
| 2022-12-31 | $4.21K 10-K · filed 2024-03-25 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $4.21K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $4.21K 10-Q · filed 2022-07-08 | ||
| 2021-12-31 | $0.00 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |